“By building on the exciting advantages of Pod therapy, we are always looking to provide pioneering technology that simplifies life and offers freedom so our users can enjoy fulfilling lives without limitations. “We listen closely to our customers to incorporate their insight and feedback into our development process to create innovative products that meet their needs,” said Bret Christensen, Insulet Chief Commercial Officer. It allows individuals to discreetly manage their diabetes via an intuitive, color touch-screen Personal Diabetes Manager that is a locked-down smartphone, bringing greater freedom and flexibility to simplify life. The tubeless Omnipod DASH System provides up to three days of non-stop insulin delivery, without the need for daily injections. Insulet already offers the Omnipod DASH System in the United States, United Kingdom, Netherlands, and Italy. The Omnipod DASH System is now available in Sweden, Finland, Norway, and Denmark and will be offered in France, Belgium, Germany, Austria, Switzerland, and Israel in the coming weeks. ACTON, Mass.-( BUSINESS WIRE)-Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it is commercially launching its Omnipod DASH ® Insulin Management System (Omnipod DASH System) in additional countries.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |